SCHEMBL27044

SCHEMBL27044

CCOC=C(CC)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.35
SOAT1 P35610 1/20 0.33
HCAR2 Q8TDS4 1/20 0.32
GRIK1 P39086 2/20 0.31
GRIK2 Q13002 2/20 0.31
ALDH1A1 P00352 1/20 0.31
KDM4E B2RXH2 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27043 1.00 FFAR3 (0.35) FFAR3SOAT1HCAR2GRIK1GRIK2
SCHEMBL3555075 1.00 FFAR3 (0.35) FFAR3SOAT1HCAR2GRIK1GRIK2
SCHEMBL984690 0.86 FFAR3 (0.32) FFAR3SOAT1HCAR2
SCHEMBL12801028 0.84 HCAR2 (0.31) HCAR2GRIK1GRIK2
SCHEMBL30965305 0.82 HCAR2 (0.46) SOAT1HCAR2ALDH1A1
SCHEMBL31058784 0.82 HCAR2 (0.46) SOAT1HCAR2ALDH1A1
Benzophenone SCHEMBL10712584 0.82 ELANE (0.47) ALDH1A1
SCHEMBL28845613 0.82 TSHR (0.46) FFAR3HCAR2ALDH1A1KDM4ETSHR
SCHEMBL6308241 0.82 HDAC3 (0.39) FFAR3HCAR2GRIK1GRIK2ALDH1A1
SCHEMBL18044751 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111303336-A Water transfer printing tearable film resin, preparation method thereof and water transfer printing tearable film composition 广东鲸鲨化工有限公司 2020-06-19 CN claimed
EP-2757133-B1 UV-CURABLE INK FOR DIRECT PLATE MAKING BY INK-JET PRINTING WITH PREPARATION METHOD AND APPLICATION THEREFOR INST CHEMISTRY CAS (CN) 2016-12-28 EP claimed
EP-2807026-A1 MULTILAYER SYSTEMS LANXESS Deutschland GmbH (DE) 2014-12-03 EP claimed
WO-2013110610-A1 MULTILAYER SYSTEMS LANXESS DEUTSCHLAND GMBH (DE) 2013-08-01 WO claimed
EP-2620277-A1 Multi-layer systems LANXESS Deutschland GmbH (DE) 2013-07-31 EP claimed
US-6677008-B2 IMAGE RECEIVER SHEET; MIXTURE OF SHELL-CORE POLYMER AND FILLER EASTMAN KODAK COMPANY 2004-01-13 US claimed
EP-1132217-B1 Ink-jet recording element containing coated particles EASTMAN KODAK CO (US) 2003-06-18 EP claimed
US-20020155260-A1 Ink jet recording element EASTMAN KODAK COMPANY 2002-10-24 US claimed
US-6375320-B1 Ink jet printing method EASTMAN KODAK COMPANY 2002-04-23 US claimed
EP-1132218-A1 Ink jet printing method EASTMAN KODAK COMPANY (US) 2001-09-12 EP claimed
EP-1132217-A1 Ink-jet recording element containing coated particles EASTMAN KODAK COMPANY (US) 2001-09-12 EP claimed
EP-0132851-B1 5-SUBSTITUTED(1,2,4)TRIAZOLO(1,5-C)PYRIMIDIN-2-AMINES AMERICAN CYANAMID COMPANY (US) 1989-10-04 EP claimed
EP-4545515-A1 BCL-2 INHIBITORS BeiGene Switzerland GmbH (CH) 2025-04-30 EP disclosed
US-12227507-B2 Pharmaceutical compounds PFIZER INC. (US) 2025-02-18 US disclosed
CN-114555604-B Pharmaceutical compounds 辉瑞公司 2024-11-15 CN disclosed
US-20240376104-A1 Bcl-2 Inhibitors BEIGENE LTD. (KY) 2024-11-14 US disclosed
US-5177116-A Polysiloxane BASF CORPORATION (US) 1993-01-05 US disclosed
US-4795693-A RUBBER MODIFIED EPOXY RESIN AMERICAN TELEPHONE AND TELEGRAPH COMPANY, AT&T TECHNOLOGIES, INC. (US) 1989-01-03 US disclosed
US-4628022-A PHOTORESIST IS RUBBER MODIFIED EPOXY COMPOUND AT&T TECHNOLOGIES, INC. (US) 1986-12-09 US disclosed
US-4511757-A Circuit board fabrication leading to increased capacity AT&T TECHNOLOGIES, INC. (US) 1985-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227507-B2 Pharmaceutical compounds CHRNA6, GABRA6, CHRNA7 FFAR3 684/4885SOAT1 1440/4885HCAR2 378/4885
US-20240376104-A1 Bcl-2 Inhibitors BCL2, BCL2L1, BCL2L2 FFAR3 2823/4885SOAT1 2303/4885HCAR2 2165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.